(Q44238976)

1 December 2017

Pavlovian conditioning of L-dopa induced movement (English)

1 reference

1 December 2017

R J Carey

1

1 reference

1 December 2017

1 January 1992

1 reference

1 December 2017

1 reference

1 December 2017

107

1 reference

1 December 2017

203-210

1 reference

1 December 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245138

1 December 2017

0 references

cites work

Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245138

Reinstatement by caffeine of an extinguished conditioned dopaminergic drug response.

21 January 2018

1 reference

12 December 2020

Pharmacological basis of akinesia in Parkinson's disease.

1 reference

12 December 2020

Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons

1 reference

12 December 2020

Simultaneous multiple electrode liquid chromatographic-electrochemical assay for catecholamines, indole-amines and metabolites in brain tissue

1 reference

12 December 2020

Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.

1 reference

12 December 2020

Conditioned turning in rats: dopaminergic involvement in the initiation of movement rather than the movement itself.

1 reference

12 December 2020

Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.

1 reference

12 December 2020

Video image analysis of behavior by microcomputer: categorization of turning and locomotion after 6-OHDA injection into the substantia nigra.

1 reference

12 December 2020

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

12 December 2020

The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P.

1 reference

12 December 2020

Conditioning the placebo response in the rotational model of Parkinson's disease.

1 reference

12 December 2020

Antiparkinsonian effects of caffeine depend upon pavlovian drug conditioning processes

1 reference

12 December 2020

Turning behaviour in animals

1 reference

12 December 2020

Mechanism of action of short- and long-term L-DOPA treatment in parkinsonism: role of the surviving nigrostriatal dopaminergic neurons

1 reference

12 December 2020

Carbidopa effect on rat brain monoamine oxidase and pineal melatonin.

1 reference

12 December 2020

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

1 reference

12 December 2020

Short-term effects of ether, equithesin and droperidol/fentanyl on catecholamine and indolamine metabolism in the brain of the rat.

1 reference

12 December 2020

A conditioned anti-parkinsonian drug effect in the hemi-parkinsonian rat.

1 reference

12 December 2020

Opioid binding sites in the nigrostriatal system of the guinea pig are not located on nigral dopaminergic neurons

1 reference

12 December 2020

Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis

1 reference

12 December 2020

Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.

1 reference

12 December 2020

Interhemispheric nigrostriatal projections in the rat: Bifurcating nigral projections and loci of crossing in the diencephalon

1 reference

12 December 2020

Conditioning of rotational behavior after the administration of a single dose of apomorphine in rats with unilateral denervation of the dopaminergic nigrostriatal pathway: relevance to drug addiction.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245138

1 reference

1 December 2017

1 reference

PubMed ID

1615121